Stock Events

Stock Events

GSK 

$25.50
11746
+$0.52+2.08% Thursday 14:36

Statistics

Day High
25.58
Day Low
25.58
52W High
31.48
52W Low
18.99
Volume
308
Avg. Volume
792
Mkt Cap
51.07B
P/E Ratio
13.98
Dividend Yield
3.61%
Dividend
0.92

Upcoming

Dividends

3.61%Dividend Yield
Jul 26
$0.23
Apr 26
$0.24
Jan 26
$0.21
Oct 25
$0.21
Jul 25
$0.22
10Y Growth
-4.42%
5Y Growth
-7.7%
3Y Growth
5.08%
1Y Growth
8.06%

Earnings

28OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.32
0.46
0.6
0.74
Expected EPS
0.6961667879
Actual EPS
N/A

Financials

1.66%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
43.76BRevenue
725.34MNet Income

Analyst Ratings

0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GLAXF. It's not an investment recommendation.
Legal & General Group
3233
LGEN.LSE
BP
2672
BP.LSE
National Grid
2470
NG.LSE
Aviva
2182
AV.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a direct competitor in the pharmaceuticals sector, competing in various therapeutic areas including vaccines.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson competes with GSK in both pharmaceuticals and consumer health products.
Merck
MRK
Mkt Cap366B
Merck & Co. is a competitor in the pharmaceuticals industry, with a strong presence in vaccines and cancer treatments.
Novartis
NVS
Mkt Cap292.35B
Novartis competes with GSK in multiple areas including respiratory and neuroscience.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes in the biopharmaceutical sector, with overlap in immunology and oncology areas.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes directly with GSK in the vaccines market and other pharmaceutical areas.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca competes in various pharmaceutical areas including respiratory, cardiovascular, and oncology, similar to GSK.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb competes in the pharmaceutical sector, particularly in cancer and cardiovascular diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in pharmaceuticals and diagnostics, with a strong focus on oncology and immunology.
AMGEN
AMGN
Mkt Cap233.78B
Amgen competes in the biotech sector, with products that overlap with GSK’s offerings in areas like bone health and oncology.

About

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Show more...
CEO
Luke Victor Miels
Employees
66841
Country
United Kingdom
ISIN
GB00BN7SWP63
WKN
000A3DMB5

Listings

MX
MX
GSKN.MX
MX
MX
GSK1N.MX
XETRA
DE
GS71.XETRA
STU
DE
GS71.STU

0 Comments

Share your thoughts

FAQ

What is GSK stock price today?▼
The current price of GLAXF is $25.50 USD — it has increased by +2.08% in the past 24 hours. Watch GSK stock price performance more closely on the chart.
What is GSK stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange GSK stocks are traded under the ticker GLAXF.
Is GSK stock price growing?▼
GLAXF stock has fallen by -0.31% compared to the previous week, the month change is a +3.24% rise, over the last year GSK has showed a +25.31% increase.
What is GSK market cap?▼
Today GSK has the market capitalization of 51.07B
When is the next GSK earnings date?▼
GSK is going to release the next earnings report on October 28, 2026.
What were GSK earnings last quarter?▼
GLAXF earnings for the last quarter are 0.67 USD per share, whereas the estimation was 0.62 USD resulting in a +8.72% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GSK revenue for the last year?▼
GSK revenue for the last year amounts to 43.76B USD.
What is GSK net income for the last year?▼
GLAXF net income for the last year is 725.34M USD.
Does GSK pay dividends?▼
Yes, GLAXF dividends are paid quarterly. The last dividend per share was 0.23 USD. As of today, Dividend Yield (FWD)% is 3.61%.
How many employees does GSK have?▼
As of September 04, 2026, the company has 66,841 employees.
In which sector is GSK located?▼
GSK operates in the Health & Wellness sector.
When did GSK complete a stock split?▼
The last stock split for GSK was on July 19, 2022 with a ratio of 4:5.
Where is GSK headquartered?▼
GSK is headquartered in London, United Kingdom.